Nusinersen Use in Spinal Muscular Atrophy

The American Academy of Pediatrics has endorsed the following publication: Michelson D, Ciafaloni E, Ashwal S, et al; American Academy of Neurology. Evidence in focus: Nusinersen use in spinal muscular atrophy. Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology [published online ahead of print October 12, 2018]. Neurology. doi: 10.1212/WNL.0000000000006502. Available at: http://n.neurology.org/content/neurology/early/2018/10/12/WNL.0000000000006502.full.pdf.

All statements of endorsement from the American Academy of Pediatrics automatically expire 5 years after publication unless reaffirmed, revised, or retired at or before that time.